Harbour BioMed Overview
- Founded
- 2016
- Status
- Private
- Employees
- 71
- Latest Deal Type
- Series C
- Latest Deal Amount
- $103M
- Investors
- 18
Harbour BioMed General Information
Description
Developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1 Broadway, 14th Floor
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Harbour BioMed Timeline
Harbour BioMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 09-Jul-2020 | $103M | 00000 | Completed | Generating Revenue | |
| 4. Early Stage VC (Series B1) | 12-Mar-2020 | 0000 | 00000 | Completed | Clinical Trials - General | |
| 3. Early Stage VC (Series B) | 26-Aug-2018 | 0000 | 00000 | Completed | Clinical Trials - General | |
| 2. Early Stage VC | 22-Jan-2018 | $50M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 01-Dec-2016 | $50M | $50M | Completed | Startup |
Harbour BioMed Competitors (36)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioAtla | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 00000 00000 | 000.00 |
| 000000 | Formerly PE-Backed | Paris, France | 00 | 000.00 | 000000000 | 000.00 |
| 000000 00000000000 | Corporation | PA | 000 | 000.00 | 00000000 | 000.00 |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 00000000 | Venture Capital-Backed | Rockville, MD | 000.00 | 0000000000 0 | 000.00 |
Harbour BioMed Executive Team (8)
1 Former Executive
Harbour BioMed Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jingsong Wang MD | Harbour BioMed | Co-Founder, Chairman & Chief Executive Officer | 000 0000 |
Harbour BioMed Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Country Garden Venture Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Hudson Bay Capital Management | Hedge Fund | Minority | 000 0000 | 000000 0 | |
| Octagon Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| OrbiMed | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Sage Partners | Corporation | Minority | 000 0000 | 000000 0 |
Harbour BioMed Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000000 | 19-Dec-2016 | 000000000000000000 | Biotechnology | 00000000 0000 00 |
Ready to get started?
Request a free trial
Harbour BioMed Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 0000000000 | Biotechnology | 0000 |